PRESS RELEASE published on 06/24/2024 at 12:01, 2 years 4 months ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2024 Publication des droits de vote et actions composant le capital de la société conformément à la réglementation en vigueur Capital Droits De Vote Actions Réglementation Société
BRIEF published on 05/24/2024 at 17:50, 2 years 5 months ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
BRIEF published on 05/24/2024 at 17:50, 2 years 5 months ago Hugues Lecat nommé président du conseil d'administration de Guerbet Rendez-vous Hugues Lecat Solutions D'IA Planche Guerbet L'imagerie Médicale
PRESS RELEASE published on 05/24/2024 at 17:45, 2 years 5 months ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 2 years 5 months ago Nombre d'actions et de droits de vote de Guerbet au 30 avril 2024 Droits De Vote Capital Social Actions Transparence Guerbet
BRIEF published on 05/21/2024 at 12:12, 2 years 5 months ago Number of Guerbet shares and voting rights as of April 30, 2024 Share Capital Voting Rights Actions Transparency Guerbet
PRESS RELEASE published on 05/21/2024 at 12:07, 2 years 5 months ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2024 Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société conformément à la réglementation en vigueur Déclaration Droits De Vote Capital Social Actions Réglementation
BRIEF published on 03/20/2024 at 18:05, 2 years 7 months ago Changements Importants au Conseil d'Administration de Guerbet Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat Pharmaceutique
BRIEF published on 03/20/2024 at 18:05, 2 years 7 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 2 years 7 months ago Guerbet: Evolution du Conseil d’Administration de Guerbet. Annonce de l'évolution du Conseil d'Administration de Guerbet avec la nomination de Hugues Lecat en qualité de censeur et futur Président, et déclarations des principaux intéressés Assemblée Générale Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat
Published on 11/09/2026 at 23:10, 8 hours 35 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 8 hours 45 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 9 hours 13 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 9 hours 30 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 07:38, 6 minutes ago Elmos Semiconductor SE continues profitable growth and strong cash generation in the third quarter of 2026
Published on 11/10/2026 at 07:30, 14 minutes ago Henkel posts very strong sales growth in the third quarter
Published on 11/10/2026 at 07:30, 15 minutes ago R. STAHL sales and profitability on track after nine months – Stabilization continues as planned – Forecast for 2026 confirmed
Published on 11/10/2026 at 07:30, 15 minutes ago Infineon closes FY 2026 with record quarter; expects revenue growth of more than 20 percent and a 5-percentage-point increase in profitability for FY 2027
Published on 11/10/2026 at 07:30, 15 minutes ago AUTO1 Group appoints Jörg Pietzner as Chief Financial Officer
Published on 11/10/2026 at 07:00, 45 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 45 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 13 hours 15 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 13 hours 15 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
